Allergy Awareness Week is fast approaching ⏰ #AllergyAwarenessWeek

Make sure you know what to do in the case of an #Anaphylaxis emergency by watching our video below!

Learn more➡️ bit.ly/4ahPJXr

📢 We've approved fosdenopterin to treat adult patients with molybdenum cofactor deficiency (MoCD) Type A

Find out more 🔗 bit.ly/3VOzgpF

📢 We've approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion) to treat adult patients with complicated infections of the urinary tract and certain types of pneumonia.

🔗 bit.ly/3VMmw2R

🛎️ Following our approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant 🛎️

Read the case study here 🔗 bit.ly/3xbe1UN

Today is #PurpleDay , the International Day of Epilepsy.

Did you know that 1 in 100 people in the UK have epilepsy? Share this infographic to show your support and help people to know what to do if they were to see someone having a seizure. 💜

#StampOutSeizures #epilepsy

Thousands of counterfeit or unbranded copies of LifeVac anti-choking devices are being sold across the UK 🚨

We’re warning the public not to buy counterfeit or unbranded devices as they do not comply with device regulations and could cause harm 🔗 bit.ly/3vqFUaZ

📢 It’s World Tuberculosis (TB) Day! 📢

Our Principal Scientist, Bhagwati Khatri has written a blog about #TB and how we’re contributing to eliminating the disease.

Yes! We can #ENDTB together 🤝

🔗 bit.ly/43xmOwh

⚖️ SENTENCED ⚖️

Disgraced company director convicted of falsifying medicine quality data.

Read the full story here 👉 bit.ly/3Tm6biw

📢 We've approved Etrasimod to treat patients over the age of 16 with ulcerative colitis  

Find out more 🔗 bit.ly/4cdS5Z9

📢 We've approved Quizartinib to treat adult patients with a type of blood cancer

Find out more 🔗 bit.ly/4cogH1J

We support International Women’s Day 2024 💜 #IWD2024

This year’s theme is #InspireInclusion 🫶 Our Head of our Good Clinical Practice team, Mandy Budwal-Jagait, discusses why it’s important for us to inspire inclusion in the workplace.

Read the blog🔗 bit.ly/3wO3LSo

📢 We've approved Ganaxolone as a first anti-seizure medication to treat patients with rare epileptic seizure disorder

Find out more 🔗 bit.ly/4a4LkqD

📢 We've approved Rozanolixizumab to treat adult patients with the autoimmune disease generalised myasthenia gravis

Find out more 🔗 bit.ly/3uZbQmE

📢 We've approved Piflufolastat as a diagnostic tool for adults with prostate cancer

Find out more 🔗 bit.ly/3V3geLW

📢 We've approved Rubidium (Rb82) Generator as a diagnostic tool for people with heart disease

Find out more 🔗 bit.ly/4371U7l

⚠️ Codeine linctus to be reclassified to a prescription-only medicine because of risk of abuse and addiction ⚠️

Read more here 🔗 bit.ly/3wn5TAh

🔎 Explore the legacy of key figures in medicine and healthcare, including LGBT individuals and those who had positive impacts for the community.

#LGBTHistoryMonth

From today, you can now use the NHS App to access prescriptions for the very first time, allowing you to track when your prescriptions are issued and view your prescribed medication.

Find out more ➡️ nhs.uk/nhs-app/nhs-ap…

It’s #LGBTHistoryMonth !

This month we're looking #UnderTheScope and shining light on the impact of LGBT individuals in medicine and healthcare, both past and present.

📢 We've approved the medicine Omjjara (momelotinib) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia  

Find out more 🔗 bit.ly/42j9iMq